Mural Oncology (MURA)
NASDAQ: MURA
· Real-Time Price · USD
1.77
0.00 (0.00%)
At close: Aug 15, 2025, 3:59 PM
1.79
1.13%
After-hours: Aug 15, 2025, 05:02 PM EDT
Mural Oncology Balance Sheet Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Dec 31, 2022 |
Cash & Equivalents | 77.09M | 106.68M | 115.46M | 111.02M | 121.59M | 107.26M | 270.85M | -16.48M | 273.34M | -19.39M |
Short-Term Investments | n/a | 1M | 28.92M | 64.48M | 83.12M | 124.41M | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | 1.97M | 1.97M | 258K | n/a | n/a | n/a |
Other Long-Term Assets | n/a | 1.97M | 1.98M | 2M | 61K | 77K | n/a | 181K | 1.66M | n/a |
Receivables | n/a | 55K | 51K | 1.39M | 1M | 1.9M | 5.55M | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | 150K | n/a | n/a | n/a |
Other Current Assets | 4.46M | 711K | 805K | 751K | 628K | 620K | 787K | 2.7M | n/a | 1.83M |
Total Current Assets | 81.56M | 117.65M | 152.92M | 183.79M | 213.06M | 239.43M | 277.34M | 4.96M | 274.82M | 4.82M |
Property-Plant & Equipment | 6M | 12.46M | 14.5M | 17.48M | 19.84M | 22.03M | 24.15M | 25.06M | 24.5M | 28.93M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 6M | 14.43M | 16.48M | 19.48M | 21.87M | 24.08M | 24.41M | 25.24M | 26.16M | 28.93M |
Total Assets | 87.56M | 132.08M | 169.39M | 203.27M | 234.93M | 263.5M | 301.75M | 30.2M | 300.98M | 33.75M |
Account Payables | 3.14M | 1.88M | 2.06M | 2.24M | 3.11M | 1.57M | 5.97M | 3.5M | n/a | 2.97M |
Deferred Revenue | n/a | n/a | n/a | n/a | 1.72M | -1.57M | n/a | n/a | n/a | n/a |
Short-Term Debt | 5.01M | n/a | 5.56M | 5.44M | 5.35M | n/a | 6.1M | 6.01M | n/a | 5.84M |
Other Current Liabilities | 20.27M | 921K | 8.16M | 5.45M | 6.27M | 10.47M | 4.99M | 5.2M | n/a | 19.8M |
Total Current Liabilities | 28.42M | 23.15M | 26.2M | 24.91M | 24.63M | 21.25M | 29.02M | 26.41M | 5.81M | 41.56M |
Long-Term Debt | 166K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 13.54M |
Other Long-Term Liabilities | 188K | 235K | 235K | 115K | n/a | n/a | n/a | 219K | n/a | -13.24M |
Total Long-Term Liabilities | 354K | 1.04M | 2.7M | 4.22M | 5.73M | 7.33M | 8.91M | 10.69M | 10.65M | 13.85M |
Total Liabilities | 28.77M | 24.19M | 28.89M | 29.13M | 30.36M | 28.58M | 37.93M | 37.09M | 16.46M | 55.41M |
Total Debt | 5.17M | 6.78M | 8.02M | 9.55M | 11.08M | 13.49M | 15.01M | 16.48M | 16.46M | 19.39M |
Common Stock | 173K | 173K | 171K | 170K | 169K | 169K | 167K | n/a | 167K | n/a |
Retained Earnings | -240.49M | -192.51M | -159.37M | -125.1M | -93.34M | -61.77M | -30.86M | n/a | n/a | n/a |
Comprehensive Income | n/a | 1K | n/a | n/a | -54K | -74K | n/a | -6.89M | n/a | -21.66M |
Shareholders Equity | 58.78M | 107.89M | 140.5M | 174.14M | 204.57M | 234.93M | 263.82M | -6.89M | 284.52M | -21.66M |
Total Investments | n/a | 1M | 28.92M | 64.48M | 85.09M | 126.38M | 258K | n/a | n/a | n/a |